Immunosenescence and infections, myth or reality?;Immunosénescence et infections, mythe ou réalité ?

Medecine et Maladies Infectieuses

Volumn 40, Issue 6, 2010, Pages 307-318

  Cretel E ^a,b   Veen, I ^b   Pierres, A ^a   Bongrand, P ^a   Gavazzi, G ^c,d  

^a INSERM   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c LABORATOIRE TIMC IMAG   (France)

^d HÔPITAL MICHALLON   (France)

Author keywords

Elderly; Immunosenescence; Infection; T cell immunity; Vaccination

Indexed keywords

PNEUMOCOCCUS VACCINE; VACCINE;

AGED; AGING; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; INFECTION; INNATE IMMUNITY; MEMORY CELL; REVIEW; SENESCENCE; VACCINATION;

ADULT; AGED; AGING; COMORBIDITY; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; IMMUNOLOGIC MEMORY; INFECTION; INFLAMMATION; LYMPHOCYTE SUBSETS; MODELS, IMMUNOLOGICAL; MYELOID CELLS; TRANSPLANTATION IMMUNOLOGY; VACCINATION;

EID: 77951573145     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2009.12.008     Document Type: Review

References (126)

1. Lloyd-Sherlock P. Population ageing in developed and developing regions: implications for health policy. Soc Sci Med 2000, 51:887-895.
2. Gavazzi G., Krause K.H. Ageing and infection. Lancet Infect Dis 2002, 2:659-666.
3. Yoshikawa T.T. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 2000, 30:931-933.
4. Leibovici L., Pitlik S.D., Konisberger H., Drucker M. Bloodstream infections in patients older than eighty years. Age Ageing 1993, 22:431-442.
5. Bürkle A., Caselli G., Franceschi C., Mariani E., Sansoni P., Santoni A., et al. Pathophysiology of ageing, longevity and age related diseases. Immunol Ageing 2007, 2(4):4.
6. Lesourd B. Modification de la réponse immune chez le sujet âgé. Rev Rhum 2004, 71:446-454.
7. Aw D., Silva A.B., Palmer D.B. Immunosenescence: emerging challenges for an ageing population. Immunology 2007, 120:435-446.
8. Pawelec G. Immunosenescence: impact in the young as well as the old?. Mech Ageing Dev 1999, 108:1-7.
9. Ligthart G.J., Corberand J.X., Fournier C., Galanaud P., Hijmans W., Kennes B., et al. Admission criteria for immunogerontological studies in man: the senieur protocol. Mech Ageing Dev 1984, 28:47-55.
10. Wick G., Grubeck-Loebenstein B. The aging immune system: primary and secondary alterations of immune reactivity in the elderly. Exp Gerontol 1997, 32:401-413.
11. Rowe J.W., Kahn R.L. Aging (Milano). Successful aging 1998, 10(2):142-144.
12. Gomez C.R., Boehmer E.D., Kovacs E.J. The aging innate immune system. Curr Opin Immunol 2005, 17:457-462.
13. Fujihashi K., Kiyono H. Mucosal immunosenescence: new developments and vaccines to control infectious diseases. Trends Immunol 2009, 30:334-342.
14. Incalzi R.A., Maini C.L., Fuso L., Giordano A., Carbonin P.U., Galli G. Effects of aging on mucociliary clearance. Compr Gerontol [A] 1989, 3:65-68.
15. Cogné M. Immunosénescence. Vieillissement: les données biologiques 2005, 55-70. Elsevier.
16. Meyer K.C. The role of immunity in susceptibility to respiratory infection in the aging lung. Respir Physiol 2001, 128:23-31.
17. Arai T., Yasuda Y., Takaya T., Toshima S., Kashiki Y., Shibayama M., et al. Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, and pneumonia in elderly hypertensive patients with stroke. Chest 2001, 119:660-661.
18. Morimoto S., Okhaishi K., Onishi M., Katsuya T., Yang J., Okuro M., et al. Deletion allele of the angiotensin-converting enzyme gene as a risk factor for pneumonia in elderly patients. Am J Med 2002, 112:89-94.
19. De Wazières B. Infectious pneumonia in the elderly. Rev Mal Respir 2007, 4(6):799-802.
20. Palmer L.B., Albulak K., Fields S., Filkin A.M., Simon S., Smaldone G.C. Oral clearance and pathogenic oropharyngeal colonization in the elderly. Am J Respir Crit Care Med 2001, 164(3):464-468.
21. Yoneyama T., Yoshida M., Ohrui T., Mukaiyama H., Okamoto H., Hoshiba K., et al. Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc 2002, 50:430-433.
22. Stamm W.E., Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 1999, 28:723-725.
23. Salles N. Basic mechanisms of the aging gastrointestinal tract. Dig Dis 2007, 25:112-117.
24. Parlesak A., Klein B., Schecher K., Bode J.C., Bode C. Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J Am Geriatr Soc 2003, 51:768-773.
25. Toutous-Trellu L., Michel J.P., Perrenoud J.J. Practicing dermatology in an integrated geriatric Swiss hospital. J. Am Geriatr Soc 2008, 56:1984-1985.
26. Kaya G, Saurat JH. Dermatoporosis: a chronic cutaneous insufficiency/fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments.Dermatology. 2007;215(4):284-94.
27. Franceschi C., Valensin S., Fagnoni F., Barbi C., Bonafè M. Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exp Gerontol 1999, 34:911-921.
28. Fulop T., Larbi A., Douziech N., Fortin C., Guérard K.P., Lesur O., et al. Signal transduction and functional changes in neutrophils with aging. Aging Cell 2004, 3:217-226.
29. Bongrand P., Bartolin R., Bouvenot G., Arnaud C., Delboy C., Depieds R. Effect of age on different receptors and functions of phagocytic cells. J Clin Lab Immunol 1984, 15(1):45-50.
30. Panda A., Arjona A., Sapey E., Bai F., Fikrig E., Montgomery R.R., et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009, 30:325-333.
31. Butcher S.K., Killampalli V., Lascelles D., Wang K., Alpar E.K., Lord J.M. Raised cortisol: DHEAS ratios in the elderly after injury: potential impact upon neutrophil function and immunity. Aging Cell 2005, 4:319-324.
32. Castle S.C. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000, 31:578-585.
33. Pawelec G., Larbi A. Immunity and ageing in man: Annual review 2006/2007. Exp Gerontol 2008, 43:34-38.
34. Martins P.N.A., Pratschke J., Pascher A., Fritsche L., Frei U., Neuhaus P., et al. Age and immune response in organ transplantation. Transplantation 2005, 79:127-132.
35. Ginaldi L., De Martinis M., D'Ostilio A., Marini L., Loreto M.F., Quaglino D. The immune system in the elderly III. Innate Immunity. Immunol Res 1999, 20:117-126.
36. Ogata K., Yokose N., Tamura H., An E., Nakamura K., Dan K., et al. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol 1997, 84:269-275.
37. Franceschi C., Monti D., Sansoni P., Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995, 15:12-16.
38. Cossarizza A., Ortolani C., Monti D., Franceschi C. Cytometric analysis of immunosenescence. Cytometry 1997, 27:297-313.
39. Moulias S. Nutrition and immunity in the elderly. Ann Med Interne (Paris) 2002, 153:446-449.
40. Landgren O., Kyle R.A., Pfeiffer R.M., Katzmann J.A., Caporaso N.E., Hayes R.B., et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009, 113(22):5412-5417.
41. Ginaldi L., De Martinis M., D'Ostilio A., Marini L., Loreto M.F., Corsi M.P., et al. The immune system in the elderly I. Specific humoral immunity. Immunol Res 1999, 20:101-108.
42. Ginaldi L., Loreto M.F., Corsi M.P., Modesti M., De Martinis Immunosenescence and infectious diseases. Microbes Infect 2001, 3:851-857.
43. Hakim F.T., Cepeda R., Kaimei S., Mackall C.L., McAtee N., Zujewski J., et al. Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 1997, 90:3789-3798.
44. Mackall C.L., Fleisher T.A., Brown M.R., Andrich M.P., Chen C.C., Feuerstein I.M., et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995, 332:143-149.
45. Mackall C.L., Fleisher T.A., Brown M.R., Andrich M.P., Chen C.C., Feuerstein I.M., et al. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997, 89:3700-3707.
46. Mackall C.L., Hakim F.T., Gress R.E. T-cell regeneration: all repertoires are not created equal. Immunol Today 1997, 18:245-251.
47. Sansoni P., Fagnoni F., Vescovini R., Mazzola M., Brianti V., Bologna G., et al. T lymphocyte proliferative capability to defined stimuli and costimulatory CD28 pathway is not impaired in healthy centenarians. Mech Ageing Dev 1997, 96:127-136.
48. Mazari L., Lesourd B.M. Nutritional influences on immune response in healthy aged persons. Mech Ageing Dev 1998, 104:25-40.
49. Effros R.B. Replicative senescence of CD8 T cells: effect on human ageing. Exp Gerontol 2004, 39(4):517-524.
50. Cawthorn R.M., Smith K.R., O'Brien E., Sivatchenko A., Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003, 361:393-395.
51. Lesourd B., Mazari L. Nutrition and immunity in the elderly. Proc Nutr Soc 1999, 58(3):685-695.
52. Akha A.A.S., Miller R.A. Signal transduction and the aging immune system. Curr Opin Immunol 2005, 17:486-491.
53. Haynes L. The effect of aging on cognate function and development of immune memory. Curr Opin Immunol 2005, 17:476-479.
54. Weng N., Akbar A.N., Goronzy J. CD28- T cells: their role in the age-associated decline of immune function. Trends Immunol 2009, 30(7):306-312.
55. Chen W.H., Kozlovsky B.F., Effros R.B., Grubeck-Loebenstein B., Edelman R., Sztein M.B. Vaccination in the elderly: an immunological perspective. Trends Immunol 2009, 30:351-359.
56. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002, 8:379-385.
57. Looney R.J., Falsey A., Campbell D., Torres A., Kolassa J., Brower C., et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999, 90:213-219.
58. Kuijpers T.W., Vossen M.T., Gent M.R., Davin J.C., Roos M.T. Wertheim-van Dillen PM, et al. Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV. J Immunol 2003, 170:4342-4348.
59. Khan N., Shariff N., Cobbold M., Bruton R., Ainsworth J.A., Sinclair A.J., et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002, 15(169):1984-1992. 4.
60. Goronzy J.J., Weyand C.M. T cell development and receptor diversity during aging. Curr Opin Immunol 2005, 17:468-475.
61. Burns E.A., Goodwin J.S. Immunodeficiency of aging. Drugs Aging 1997, 11:374-397.
62. Castle S., Uyemura K., Wong W., Modlin R., Effros Rl. Evidence of enhanced type 2 response and impaired upregulation of type 1 response in frail elderly nursing home residents. Mech Ageing Dev 1997, 94:7-16.
63. Castle S., Uyemura K., Crawford W., Wong W., Klaustermeyer W.B., Makinodan T. Age-related impaired proliferation of peripheral blood mononuclear cells is associated with an increase in both IL-10 and IL-12. Exp Gerontol 1999, 34:243-252.
64. Tamir A., Eisenbraun M.D., Garcia G.G., Miller R.A. Age-dependent alterations in the assembly of signal transduction complexes at the site of T cell/APC interaction. J Immunol 2000, 165:1243-1251.
65. Garcia G.G., Miller R.A. Single-cell analyses reveal two defects in peptide-specific activation of naive T cells from aged mice. J Immunol 2001, 166:3151-3157.
66. Fulop T., Wagner R., Abdelouhed K., Weber J., Trottier L., Payette E. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects. J Gerontol 1999, 54:M59-64.
67. Fulop T., Pawelec G., Castle S., Loeb M. Immunosenescence and Vaccination in nursing home residents. CID 2009, 48:443-448.
68. Ponnappan U., Zhong M., Trebilcock G.U. Decreased proteasome-mediated degradation in T cells from the elderly: A role in immune senescence. Cell Immunol 1999, 192:167-174.
69. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
70. He H.T., Lellouch A., Marguet D. Lipid rafts and the initiation of T cell receptor signaling. Semin Immunol 2005, 17:23-33.
71. Castle S., Uyemura K., Fulop T., Makinodan T. Host resistance and immune responses in advanced age. Clin Geriatr Med 2007, 23:463-479.
72. Olsson J., Wikby A., Johansson B., Löfgren S., Nilsson B.O., Ferguson F.G. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000, 121:187-201.
73. Wikby A., Ferguson F., Forsey R., Thompson J., Strindhall J., Löfgren S., et al. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci 2005, 60:556-565.
74. Ershler W.B., Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, frailty. Annu Rev Med 2000, 51:245-270.
75. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger W.H.J., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in elderly. Am J Med 1999, 106:506-512.
76. Ferrucci L., Harris T.B., Guralnik J.M., Tracy R.P., Corti M.C., Cohen H.J., et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999, 47:639-646.
77. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., et al. Inflamm-Aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000, 244-254.
78. Wick G., Jansen-Dürr P., Berger P., Blasko I., Grubeck-Loebenstein B. Diseases of aging. Vaccine 2000, 18:1567-1583.
79. Shoenfeld Y., Sherer Y., Harats D. Artherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol 2001, 22:293-295.
80. Reuben D.B., Cheh A.I., Harris T.B., Ferrucci L., Rowe J.W., Tracy R.P., et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002, 50:638-644.
81. Brüünsgaard H., Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 2003, 23:15-39.
82. Van Der Biggelaar A.H., Huizinga T.W., De Craen A.J., Gussekloo J., Heijmans B.T., Frölich M., et al. impaired innate immunity predicts frailty in old age. The leiden-85 plus study. Exp Gerontol 2004, 39:1407-1414.
83. Gavazzi G., Mallaret M.R., Couturier P., Iffenecker A., Franco A. Bloodstream infection: differences between young-old, old, and old-old patients. J Am Geriatr Soc 2002, 50(10):1667-1673.
84. High K.P. Infection as cause of age-related morbidity and mortality. Ageing Res Rev 2004, 3:1-14.
85. Aubert T., Rovery C., Bourhaba K., Singeorzan S., Heim M., Crétel E. Non necrotizing bacterial cellulitis and bacteriemia due to Shewanella putrefaciens. Rev Med Interne 2009, 30:800-802.
86. Fagnoni F.F., Vascovini R., Passeri G., Bologna G., Pedrazzoni M., Lavagetto G., et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999, 47:639-646.
87. Sehl M.E., Yates F.E. Kinetics of human aging: I. Rates of senescence between ages 30 and 70 years in healthy people. J Gerontol A Biol Sci Med Sci. 2001, 56:B198-208.
88. Castle S.C., Uyemura K., Rafi A., Akande O., Makinodan T. Comorbidity is a better predictor of impaired immunity than chronological age in older adults. J Am Geriatr Soc 2005, 53(9):1565-1569.
89. Katona P., Katona-Apte J. The interaction between nutrition and infection. Clin Infect Dis 2008, 46:1582-1588.
90. Cederholm T., Wretlind B., Hellström K., Andersson B., Engström L., Brismar K., et al. Enhanced generation of interleukins 1 beta and 6 may contribute to the cachexia of chronic disease. Am J Clin Nutr 1997, 65(3):876-882.
91. Traber M.G., Atkinson J., Vitamin E. antioxidant and nothing more. Free Radic Biol Med 2007, 43:4-15.
92. Meydani S.N., Barklund M.P., Liu S., Meydani M., Miller R.A., Cannon J.G., et al. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr 1990, 52:557-563.
93. Meydani S.N., Meydani M., Blumberg J.B., Leka L.S., Siber G., Loszewski R., et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA. 1997, 277:1380-1386.
94. Beharka A.A., Wu D., Han S.N., Meydani S.N. Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reversed by the dietary antioxidant vitamin E. Mech Ageing Dev 1997, 93:59-77.
95. Wu D., Mura C., Beharka A.A., Han S.N., Paulson K.E., Hwang D., et al. Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am J Physiol 1998, 275:C661-C668.
96. Marko M.G., Pang H-JE, Ren Z., Azzi A., Hubber B.T., Bunnell S.C., et al. Vitamin reverses Impaired Linker for Activation of T cells Activation in T cells from aged C57BL/6 mice. J Nutr 2009, 139:1192-1197.
97. Atkinson J., Epand R.F., Epand R.M. Tocopherols and tocotrienols in membranes: a critical review. Free Radic Biol Med 2008, 44:739-764.
98. Barella L., Muller P.Y., Schlachter M., Hunziker W., Stocklin E., Spitzer V., et al. Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in rats. Biochimt Biophys Acta 2004, 1689:66-74.
99. Meydani S.N., Leka L.S., Fine B.C., Dallal G.E., Keusch G.T., Singh M.F., et al. Vitamine E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA 2004, 292:828-836.
100. Meydani S.N., Han S.N., Wu D., Vitamin E and immune response in the aged: molecular mechanisms and clinical implications. Immunol Rev 2005, 205:269-284.
101. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamine D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
102. Martineau A.R., Wilkinson R.J., Wilkinson K.A., Newton S.M., Kampmann B., Hall B.M., et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007, 176:208-213.
103. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamine D - mediated human antimicrobial response. Science 2006, 311:1770-1773.
104. Bornman L., Campbell S.J., Fielding K., Bah B., Sillah J., Gustafson P., et al. Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis 2004, 190(9):1631-1641.
105. Prasad A.S., Beck F.W., Bao B., Fitzgerald J.T., Snell D.C., Steinberg J.D., et al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 2007, 85:837-844.
106. Meydani S.N., Barnett J.B., Dallal G.E., Fine B.C., Jacques P.F., Leka L.S., et al. Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr 2007, 86:1167-1173.
107. Jassal S.V., Olpez G., Cole E. Transplantation in the elderly: a review. Geriatr Nephrol Urol 1997, 7:157-165.
108. Bradley B.A. Rejection and recipient age. Transplant Immunol 2002, 10:125-132.
109. Kasiske B.L., Chakkera H.A., Louis T.A., Ma J.Z. A meta-analysis of immunosuppression withdrawal trial in renal transplantation. J Am Soc Nephrol 2000, 11:1910-1917.
110. Ferguson F.G., Wikby A., Maxson P., Olsson J., Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and non survivors. J Gerontol A Biol Sci Med Sci 1995, 50:B378-B382.
111. Goronzy J.J., Fulbright J.W., Crowson C.S., Poland G.A., O'Fallon W.M., Weyand C.M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001, 75:12182-12187.
112. Saurwein-Teissl M., Lung T.L., Marx F., Gschösser C., Asch E., Blasko I., et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002, 168(11):5893-5899.
113. Trzonkowski P., Myśliwska J., Szmit E., Wieckiewicz J., Lukaszuk K., Brydak L.B., et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. Vaccine 2003, 21:3826-3836.
114. Chandra R.K. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 1992, 340:1124-1127.
115. Potter J.M., O'Donnel B., Carman W.F., Roberts M.A., Stott D.J. Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care. Age Ageing 1999, 28:141-145.
116. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Lewandowski R.A. The efficacy of influenza vaccine in elderly persons, A meta-analysis and review of the literature. Ann Intern Med 1995, 123:518-527.
117. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006, 36(35):337-344.
118. Mullooly J.P., Bennett M.D., Hornbrook M.C., Barker W.H., Williams W.W., Patriarca P.A., et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994, 121:947-952.
119. Bernstein E., Kaye D., Abrutyn E., Gross P., Dorfman M., Murasko D.M. Immune response to influenza vaccination in a large elderly population. Vaccine 1999, 17:82-94.
120. Carman W.F., Elder A.G., Wallace L.A., McAulay K., Walker A., Murray G.D., et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000, 355:93-97.
121. Hayward A.C., Harling R., Wetten S., Johnson A.M., Munro S., Smedley J., et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity and health service use among residents: cluster randomised controlled trial. BMJ 2006, 333:124.
122. Gavazzi G., Wazieres B., Lejeune B., Rothan-Tondeur M. Influenza and pneumococcal vaccine coverages in geriatric health care settings in France. Gerontology 2007, 53(6):382-387.
123. Delelis-Fanien A.S., Séité F., Priner M., Paccalin M. Vaccine coverage against influenza and pneumococcal infections in patients aged 65 and over: a survey on 299 outpatients. Rev Med Interne 2009, 30:656-660.
124. Fisman D.N., Abrutyn E., Spaude K.A., Kim A., Kirchner C., Daley J. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 2006, 42:1093-1101.
125. Fedson D.S., Liss C. Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults. Vaccine 2004, 22:927-946.
126. Vila-Córcoles A. Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination. J Intern Med 2009, 266(5):432-444.